Your browser doesn't support javascript.
loading
Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
Laidlaw, Tanya M; Chu, Derek K; Stevens, Whitney W; White, Andrew A.
Affiliation
  • Laidlaw TM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass. Electronic address: tlaidlaw@partners.org.
  • Chu DK; Department of Medicine, Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, Canada; Department Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Research Institute of St Joe's Hamilton, Hamilton, ON, Canada.
  • Stevens WW; Department of Medicine, Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • White AA; Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif.
J Allergy Clin Immunol Pract ; 10(6): 1462-1467, 2022 06.
Article in En | MEDLINE | ID: mdl-34999274
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sinusitis / Biological Products / Rhinitis / Nasal Polyps / Asthma, Aspirin-Induced Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sinusitis / Biological Products / Rhinitis / Nasal Polyps / Asthma, Aspirin-Induced Limits: Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2022 Document type: Article Country of publication: